Jeff Lander

Maintaining temperature integrity across a global distribution network is one of the most critical—and complex—challenges in pharmaceutical logistics. In this case study, Moderna’s logistics engineering leaders share how they are advancing cold chain reliability through predictive analytics, real-time monitoring, and proactive risk management. From manufacturing to last-mile delivery, discover how Moderna is building a smarter, more resilient cold chain.

• Examine the operational and environmental challenges of maintaining global temperature compliance for high-value, temperature-sensitive products
• Learn how predictive analytics and data-driven decision-making are being used to anticipate and prevent cold chain disruptions
• Discover practical strategies for improving end-to-end visibility, reducing excursion risk, and strengthening cold chain performance at scale

As more therapies and specialty products are delivered directly to patients’ homes, maintaining end-to-end temperature control has never been more critical—or more complex. The ship-to-home model introduces unique challenges in packaging, tracking, and patient handoff that demand innovative solutions.

This panel brings together supply chain and cold chain leaders to explore how pharmaceutical companies are evolving their temperature monitoring strategies to meet the growing demands of at-home delivery while ensuring product integrity, patient safety, and regulatory compliance.

• Building real-time visibility and control into the last mile
• Choosing the right level of monitoring: active, passive, or hybrid models
• Aligning packaging, technology, and courier services for at-home shipments
• Mitigating risk in unpredictable patient environments